Clinical trial
Tamoxifen-MRI Study
NCT00295100 · University of Pennsylvania, Other · Completed
Key facts
| NCT number | NCT00295100 |
|---|---|
| Title | Tamoxifen-MRI Study |
| Official title | Cancer Risk and Biomarkers of Tamoxifen Chemoprevention |
| Lead sponsor | University of Pennsylvania, Other |
| Collaborators | National Cancer Institute (NCI) NIH AstraZeneca Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Tamoxifen |
| Enrollment | 78 |
| Start date | Sep 1, 2000 |
| Completion | Jul 1, 2006 |
| First posted | Feb 22, 2006 |
| Last update posted | Jun 21, 2007 |
| Countries | Italy, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: